The U.S. Food and Drug Administration has approved Abeona Therapeutics' Zevaskyn (prademagene zamikeracel) for patients with ...

In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with ...

After you mail it back, your cheek cells will be tested at a lab to learn your HLA type. Then, you’ll be added to the registry and contacted if someone needs your stem cells. That could happen ...

Suzuki, R. (2025) Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants. Health, ...

"Prepare for your face to look like it was kissed by angels (and snails)." — a reviewer after experiencing this much-hyped ...

This important work presents a stochastic branching process model of tumour-immune coevolution, incorporating stochastic antigenic mutation accumulation and escape within the cancer cell population.

Galderma today announced the launch of Sculptra, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation, in China. 1-7,11-14 This follows Sculptra’s ...

No. 633773) and BD RhapsodyTM WTA Amplification Kit (BD Biosciences, Cat. No. 633801), a cDNA library with cell labels and UMI information was created based on the microbead-captured single-cell ...